US 9,211,409 · Application 12/415,671 · Granted Dec 15, 2015
US 9,211,409
Methods and systems for reducing inflammation by neuromodulation of t-cell activity
Estimated expiration
February 14, 2031
4y 149d remaining
Earliest effective filing
Mar 31, 2009
+ 20 years
Mar 31, 2029
PTA +685d
Feb 14, 2031
No TD
—
Final
Feb 14, 2031
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- March 31, 2009
- Earliest effective filing
- March 31, 2009
- Issue date
- December 15, 2015
- PTA
- +685 days
- Base expiry (before PTA)
- March 31, 2029
March 31, 2009 + 20 years = March 31, 2029 + 685 PTA days = February 14, 2031
- PRO61/072,603 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/415,671 · US 9,211,409
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,211,409: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9211409Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.